Status:
NOT_YET_RECRUITING
Comparison of Efficacy Between ILM Forceps
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Sengi
Conditions:
Macular Holes
Epiretinal Membrane
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
This study is a Single center, prospective, observational, multi surgeon randomized controlled trial. Subjects will be assessed pre-operatively, operatively and at 1 month postoperatively. Clinical ev...
Eligibility Criteria
Inclusion
- • 19y and older patients with symptomatic ERM (grade 2-3) or Macular hole (non flap-requiring) for elective ILM peeling surgery.
Exclusion
- Co-morbid diabetic retinopathy of any grade.
- Neovascular AMD.
- Previous vitrectomy.
- Previous retinal detachment treated with scleral buckle or pneumatic retinopexy.
- Uncontrolled glaucoma or previous glaucoma surgery.
- Combined phacovitrectomy.
- Macula holes with severity requiring flap.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06536569
Start Date
July 1 2025
End Date
January 1 2026
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology & Visual Sciences, St Paul's Hospital, Ophthalmology
Vancouver, British Columbia, Canada, V6Z 1Y6